161 related articles for article (PubMed ID: 7799357)
21. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
22. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone.
Dequeker J; Coppens M; Geusens P
J Rheumatol; 1991 Jun; 18(6):937. PubMed ID: 1895279
[No Abstract] [Full Text] [Related]
23. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders.
Denko CW; Boja B; Moskowitz RW
Osteoarthritis Cartilage; 1996 Dec; 4(4):245-9. PubMed ID: 11048621
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome.
Denko CW; Boja B
J Rheumatol; 2001 Jul; 28(7):1666-9. PubMed ID: 11469476
[TBL] [Abstract][Full Text] [Related]
25. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
Loeser RF; Pacione CA; Chubinskaya S
Arthritis Rheum; 2003 Aug; 48(8):2188-96. PubMed ID: 12905472
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of insulin in overweight patients with osteoarthritis of the knee.
Silveri F; Brecciaroli D; Argentati F; Cervini C
J Rheumatol; 1994 Oct; 21(10):1899-902. PubMed ID: 7837157
[TBL] [Abstract][Full Text] [Related]
27. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis.
Eckertova M; Krskova K; Penesova A; Radikova Z; Zlnay D; Rovensky J; Zorad S
Endocr Regul; 2009 Oct; 43(4):149-55. PubMed ID: 19908933
[TBL] [Abstract][Full Text] [Related]
28. Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases.
Zincarelli C; Iervolino S; Di Minno MN; Miniero E; Rengo C; Di Gioia L; Vitale D; Nicolino A; Furgi G; Pappone N
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1765-9. PubMed ID: 22623449
[TBL] [Abstract][Full Text] [Related]
29. Diffuse idiopathic skeletal hyperostosis in ancient clergymen.
Verlaan JJ; Oner FC; Maat GJ
Eur Spine J; 2007 Aug; 16(8):1129-35. PubMed ID: 17390155
[TBL] [Abstract][Full Text] [Related]
30. Serum adiponectin levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
Mader R; Novofastovski I; Schwartz N; Rosner E
Clin Rheumatol; 2018 Oct; 37(10):2839-2845. PubMed ID: 30121711
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH).
Mader R; Lavi I
Osteoarthritis Cartilage; 2009 Jun; 17(6):825-8. PubMed ID: 19176286
[TBL] [Abstract][Full Text] [Related]
32. Relationship between diffuse idiopathic skeletal hyperostosis, abdominal aortic calcification and associated metabolic disorders: Data from the Camargo Cohort.
Pariente-Rodrigo E; Sgaramella GA; Olmos-Martínez JM; Pini-Valdivieso SF; Landeras-Alvaro R; Hernández-Hernández JL
Med Clin (Barc); 2017 Sep; 149(5):196-202. PubMed ID: 28283270
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus.
Sencan D; Elden H; Nacitarhan V; Sencan M; Kaptanoglu E
Rheumatol Int; 2005 Sep; 25(7):518-21. PubMed ID: 16167164
[TBL] [Abstract][Full Text] [Related]
34. Diffuse idiopathic skeletal hyperostosis (DISH): is it of vascular aetiology?
el Miedany YM; Wassif G; el Baddini M
Clin Exp Rheumatol; 2000; 18(2):193-200. PubMed ID: 10812491
[TBL] [Abstract][Full Text] [Related]
35. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis.
Mader R; Sarzi-Puttini P; Atzeni F; Olivieri I; Pappone N; Verlaan JJ; Buskila D
Rheumatology (Oxford); 2009 Dec; 48(12):1478-81. PubMed ID: 19783587
[TBL] [Abstract][Full Text] [Related]
36. Diffuse idiopathic skeletal hyperostosis: diagnosis in a palaeopathological context.
van der Merwe AE; Maat GJ; Watt I
Homo; 2012 Jun; 63(3):202-15. PubMed ID: 22560176
[TBL] [Abstract][Full Text] [Related]
37. Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus.
Denko CW; Malemud CJ
BMC Musculoskelet Disord; 2004 Oct; 5(1):37. PubMed ID: 15496230
[TBL] [Abstract][Full Text] [Related]
38. Diffuse idiopathic skeletal hyperostosis: Forestier's disease.
Childs SG
Orthop Nurs; 2004; 23(6):375-82; quiz 383-4. PubMed ID: 15682880
[TBL] [Abstract][Full Text] [Related]
39. Diffuse idiopathic skeletal hyperostosis: Etiology and clinical relevance.
Kuperus JS; Mohamed Hoesein FAA; de Jong PA; Verlaan JJ
Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101527. PubMed ID: 32456997
[TBL] [Abstract][Full Text] [Related]
40. Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis.
Senolt L; Hulejova H; Krystufkova O; Forejtova S; Andres Cerezo L; Gatterova J; Pavelka K; Vencovsky J
Ann Rheum Dis; 2012 Jan; 71(1):71-4. PubMed ID: 21900287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
